The purpose of this study is to analyse DESR and its influence on sleep parameters in three different groups of children and adolescents: a group newly diagnosed with ADHD naïve, a group with ADHD under pharmacological treatment and a control group.
Method:
Subjects were a total of 327 children and adolescents. Two groups diagnosed with ADHD: 108 medication-naïve and 80 under pharmacological treatment; and one group with 136 healthy subjects. DESR was defined using anxious/depressed, attention problems and aggressive behaviors (AAA) scales from the Child Behavior Checklist (CBCL), and sleep through the Sleep Disturbance Scale for Children.
Results:
Significant differences were found comparing the three groups (p = .001), with a significantly higher profile on DESR in ADHD subjects, especially those who did not undergo treatment, and a positive correlation between DESR and sleep.
Conclusion:
Children and adolescents with ADHD without treatment present higher DESR than healthy controls and consequently higher sleep problems.
AchenbachM. (1999). The child behavior checklist and related instruments. Lawrence Erlbaum Associates Publishers, 1999.
2.
Al GhriwatiN.LangbergJ. M.GardnerW.PeughtJ.KelleherK. J.BaumR.BrinkmanW.B.LinchesteinP.EpsteinJ. N. (2017). Impact of mental health comorbidities on the community-based pediatric treatment and outcomes of children with attention deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 38(1), 20–28. https://doi.org/10.1097/DBP.0000000000000359
AnastopoulosA. D.SmithT. F.GarrettM. E.Morrissey-KaneE.SchatzN. K.SommerJ. L.KollinsS. C.Ashley-KochA. (2011). Self-regulation of emotion, functional impairment, and comorbidity among children with AD/HD. Journal of Attention Disorders, 15(7), 583–592. https://doi.org/10.1177/1087054710370567
5.
BarkleyR. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65–94. https://doi.org/10.1037/0033-2909.121.1.65
6.
BarkleyR. A. (2010). Differential diagnosis of adults with ADHD: The role of executive function and self-regulation. The Journal of Clinical Psychiatry, 71(7), e17. https://doi.org/10.4088/JCP.9066tx1c
7.
BarkleyR. A. (2015). Emotional dysregulation is a core component of ADHD. In BarkleyR. A. (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (4th ed., pp. 81–115). The Guilford Press.
8.
BarkleyR. A.MurphyK. R. (2009). Deficient emotional self-regulation in adults with Attention-Deficit/Hyperactivity Disorder (ADHD): The relative contributions of emotional impulsiveness and ADHD symptoms to adaptive impairments in major life activities. Journal of ADHD & Related Disorders, 1(4), 5–28. https://doi.org/10.1176/appi.ajp.2010.10081172
9.
BaykalS.NalbantogluA. (2019). An examination of emotion regulation and associated factors in Attention Deficit-Hyperactivity Disorder. Konuralp Tıp Dergisi, 11(2), 269–273. https://doi.org/10.18521/ktd.530900
10.
BiedermanJ.SpencerT.LomedicoA.DayH.PettyC. R.FaraoneS. V. (2012). Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: A family risk analysis. Psychological Medicine, 42(3), 639–646. https://doi.org/10.1017/S0033291711001644
11.
BruniO.OttavianoS.GuidettiV.RomoliM.InnocenziM.CortesiF.GiannottiF. (1996). The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. Journal of Sleep Research, 5(4), 251–261. https://doi.org/10.1111/j.1365-2869.1996.00251.x
12.
BunfordN.EvansS. W.LangbergJ. M. (2018). Emotion dysregulation is associated with social impairment among young adolescents with ADHD. Journal of Attention Disorders, 22(1), 66–82. https://doi.org/10.1177/1087054714527793
13.
Catalá-LópezF.PeiróS.RidaoM.Sanfélix-GimenoG.Gènova-MalerasR.CataláM. A. (2012). Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: A systematic review and meta-analysis of epidemiological studies. BMC Psychiatry, 12(1), 168. https://doi.org/10.1186/1471-244X-12-168
14.
ChildressA. C.SalleeF. R. (2015). Emotional lability in patients with attention-deficit/hyperactivity disorder: Impact of pharmacotherapy. CNS Drugs, 29(8), 683–693. https://doi.org/10.1007/s40263-015-0264-9
15.
ConnersC.SitareniosG.ParkerJ.EpsteinJ. (1998). The revised conners’ parent rating scale (CPRS-R): Factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology, 26(4), 257–268.
16.
DonfrancescoR.InnocenziM.MaranoA.BiedermanJ. (2014). Deficient emotional self-regulation in ADHD assessed using a unique profile of the child behavior checklist (CBCL): Replication in an Italian study. Journal of Attention Disorders, 19(10), 895–900. https://doi.org/10.1177/1087054712462884
17.
DuPaulG. J.PowerT. J.AnastopoulusA. (1998). ADHD rating scale-IV: Checklist, norms and clinical interpretation. New York, NY: The Guilford Press.
18.
FaraoneS. V. (2009). Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. P & T a Peer-Reviewed Journal for Formulary Management, 34(12), 678–694.
19.
FaraoneS. V.RostainA. L.BladerJ.BuschB.ChildressA. C.ConnorD. F.NewcornJ. H. (2019). Practitioner review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention. Journal of Child Psychology and Psychiatry, 60(2), 133–150. https://doi.org/10.1111/jcpp.12899
20.
FroehlichT. E.BrinkmanW. B.PeughJ. L.PiedraA. N.VitucciD. J.EpsteinJ. N. (2020). Pre-existing comorbid emotional symptoms moderate short-term methylphenidate adverse effects in a randomized trial of children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 30(3), 137–147. https://doi.org/10.1089/cap.2019.0125
21.
FroehlichT. E.LanphearB. P.EpsteinJ. N.BarbaresiW. J.KatusicS. K.KahnR. S. (2007). Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Archives of Pediatrics & Adolescent Medicine, 161(9), 857–864. https://doi.org/10.1001/archpedi.161.9.857
22.
GrazianoP. A.GarciaA. (2016). Attention deficit hyperactivity disorder and children’s emotion dysregulation: A meta-analysis. Clinical Psychology Review, 46, 106–123. https://doi.org/10.1016/j.cpr.2016.04.011
23.
GregoryA. M.SadehA. (2012). Sleep, emotional and behavioral difficulties in children and adolescents. Sleep Medicine Reviews, 16(2), 129–136. https://doi.org/10.1016/j.smrv.2011.03.007
24.
GruberR. (2014). ADHD, anxiety and sleep: A window to understanding the interplay between sleep, emotional regulation and attention in children?Behavioral Sleep Medicine, 12(1), 84–87. https://doi.org/10.1080/15402002.2014.862089
25.
HuangY. S.TsaiM. H.GuilleminaultC. (2011). Pharmacological treatment of ADHD and the short and long term effects on sleep. Current Pharmaceutical Design, 17(15), 1450–1458. https://doi.org/10.2174/138161211796197179
26.
HudziakJ. J.AlthoffR. R.DerksE. M.FaraoneS. VBoomsmaD. I. (2005). Prevalence and genetic architecture of Child Behavior Checklist-juvenile bipolar disorder. Biological Psychiatry, 58(7), 562–568. https://doi.org/10.1016/j.biopsych.2005.03.024
27.
HvolbyA.JørgensenN.BilenbergN. (2011). Actigraphic and parental reports of sleep difficulties in children with attention-deficity/hyperactivity disorder.Archives of Pediatrics, 162(4), 323–329. https://doi.org/10.1001/archpedi.162.4.323.
28.
KaticA.DirksB.BabcockT.SchecknerB.AdeyiB.RichardsC.FindlingR. L. (2013). Treatment outcomes with lisdexamfetamine dimesylate in children who have Attention-Deficit/Hyperactivity. Journal of Child and Adolescent Psychopharmacology, 23(6), 386–393. https://doi.org/10.1089/cap.2012.0104
29.
KutluA.ArdicU. A.ErcanE. S. (2017). Effect of methylphenidate on emotional dysregulation in children with attention-deficit/hyperactivity disorder+oppositional defiant disorder/conduct disorder. Journal of Clinical Psychopharmacology, 37(2), 220–225. https://doi.org/10.1097/JCP.0000000000000668
30.
MasiG.MiloneA.ManfrediA.BrovedaniP.PisanoS.MuratoriP. (2016). Combined pharmacotherapy-multimodal psychotherapy in children with disruptive behavior disorders. Psychiatry Research, 238, 8–13. https://doi.org/10.1016/j.psychres.2016.02.010
31.
MasiG.MuratoriP.ManfrediA.PisanoS.MiloneA. (2015). Child behaviour checklist emotional dysregulation profiles in youth with disruptive behaviour disorders: Clinical correlates and treatment implications. Psychiatry Research, 225(1–2), 191–196. https://doi.org/10.1016/j.psychres.2014.11.019
32.
MickE.BiedermanJ.PandinaG.FaraoneS. V. (2003). A preliminary meta-analysis of the child behavior checklist in pediatric bipolar disorder. Biological Psychiatry, 53(11), 1021–1027. https://doi.org/10.1016/S0006-3223(03)00234-8
33.
MoreauV.RouleauN.MorinC. M. (2014). Sleep of children with attention deficit hyperactivity disorder: Actigraphic and parental reports. Behavioral Sleep Medicine, 12(1), 69–83. https://doi.org/10.1080/15402002.2013.764526
34.
MullinB. C.HarveyA. G.HinshawS. P. (2011). A preliminary study of sleep in adolescents with bipolar disorder, ADHD, and non-patient controls. Bipolar Disorders, 13(4), 425–432. https://doi.org/10.1111/j.1399-5618.2011.00933.x
35.
National Institute for Health and Care Excellence. (2018). Attention deficit hyperactivity disorder: Diagnosis and management. NICE Guideline.
PozziM.CarnovaleC.MazharF.PeetersG. G. A. M.GentiliM.NobileM.RadiceS.ClementiE. (2019). Adverse drug reactions related to mood and emotion in pediatric patients treated for attention deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 39(4), 386–392. https://doi.org/10.1097/JCP.0000000000001058
38.
ReimherrF. W.MarchantB. K.OlsenJ. L.HallsC.KondoD. G.WilliamsE. D.RobinsonR. J. (2010). Emotional dysregulation as a core feature of adult ADHD: Its relationship with clinical variables and treatment response in two methylphenidate trials. Journal of ADHD & Related Disorders, 1(4), 53–64. https://doi.org/10.1007/s12402-015-0176-z
39.
SánchezM.LavigneR.RomeroJ. F.ElóseguiE. (2019). Emotion regulation in participants diagnosed with attention deficit hyperactivity disorder, before and after an emotion regulation intervention. Frontiers in Psychology, 10, 1092. https://doi.org/10.3389/fpsyg.2019.01092
40.
SchwartzG.AmorL. B.GrizenkoN.LageixP.BaronC.BoivinD. B.JooberR. (2004). Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. Journal of the American Academy of Child and Adolescent Psychiatry, 43(10), 1276–1282. https://doi.org/10.1097/01.chi.0000135802.94090.93
41.
SchwartzS.CorrellC. U. (2014). Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: Results from a comprehensive meta-analysis and metaregression. Journal of the American Academy of Child & Adolescent Psychiatry, 53(2), 174–187. https://doi.org/10.1016/j.jaac.2013.11.005
SpencerT. J.FaraoneS. VSurmanC. B. H.PettyC.ClarkeA.BatchelderH.WozniakJ.BiedermanJ. (2011). Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the child behavior checklist: A controlled study. Postgraduate Medicine, 123(5), 50–59. https://doi.org/10.3810/pgm.2011.09.2459
45.
SrivastavaA.CoffeyB. (2014). Emotional dysregulation in child with attention-deficit/hyperactivity disorder and anxiety: Psychopharmacological strategies. Journal of Child and Adolescent Psychopharmacology, 24(10), 590–593. https://doi.org/10.1089/cap.2014.24102
46.
SteinM. A.WeissM.HlavatyL. (2012). ADHD treatments, sleep, and sleep problems: Complex associations. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 9(3), 509–517. https://doi.org/10.1007/s13311-012-0130-0
ThomasR.SandersS.DoustJ.BellerE.GlasziouP. (2015). Prevalence of attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Pediatrics, 135(4), e994–e1001. https://doi.org/10.1542/peds.2014-3482
49.
van StralenJ. (2016). Emotional dysregulation in children with attention-deficit/hyperactivity disorder. ADHD Attention Deficit and Hyperactivity Disorders, 8(4), 175–187. https://doi.org/10.1007/s12402-016-0199-0
50.
WaxmonskyJ. G.WaschbuschD. A.BelinP.LiT.BabocsaiL.HumpheryH.PariseauM. E.BabinskiD. E.HoffmanM. T.HaakJ. L.MazzantJ. R.FabianoG. A.PettitJ. W.FallahazadN.PelhamW. E. (2016). A randomized clinical trial of an integrative group therapy for children with severe mood dysregulation. Journal of the American Academy of Child and Adolescent Psychiatry, 55(3), 196–207. https://doi.org/10.1016/j.jaac.2015.12.011
51.
WechslerD. (2007). WISC-IV: Escala de Inteligencia de Wechsler para Niños-IV (2nd ed.). TEA Ediciones.
52.
WechslerD. (2015). WISC IV Escala de Inteligencia de Wechsler para Niños-IV. TEA Ediciones.
53.
WigalS. (2009). Efficacy and safety limitations of attention hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs, 23(1), 21–31https://doi.org/10.2165/00023210-200923000-00004
54.
WilliamsK. E.SciberrasE. (2016). Sleep and self-regulation from birth to 7 years: A retrospective study of children with and without attention-deficit hyperactivity disorder at 8 to 9 years. Journal of Developmental and Behavioral Pediatrics, 37(5), 385–394. https://doi.org/10.1097/DBP.0000000000000281
